BusinessProteostasis Therapeutics Announces Closing of Follow-On Public Offering of Common StockBy Nasdaq OMXSep 14, 2016, 8:03 PM UTC
BusinessProteostasis Therapeutics, Inc. Presents New Data Demonstrating Potential for Genotype-Agnostic and Combination Therapies for People with Cystic FibrosisBy Nasdaq OMXMar 30, 2016, 6:08 PM UTC
BusinessProteostasis Therapeutics, Inc. Announces Scientific Presentations at 13th Annual European Cystic Fibrosis Society Basic Science ConferenceBy Nasdaq OMXMar 28, 2016, 11:30 AM UTC
